Clariane has announced sales of €1.31 billion for the three months to March 31, 2024, representing growth of 7.4% on a reported basis and on a like-for-like basis, due to both higher volumes and a positive pricing impact, particularly in France.

The dependency care group notes that in its nursing home business, the occupancy rate over the first three months of the year improved by 1.9 percentage points to 89.6%.

For 2024, Clariane expects continued organic sales growth of over 5%. EBITDA excluding IFRS 16, on a pro forma basis of expected disposals, should remain stable in amount.

Copyright (c) 2024 CercleFinance.com. All rights reserved.